Related references
Note: Only part of the references are listed.Trends in Postpartum Hemorrhage in the United States From 2010 to 2014
Sharon C. Reale et al.
ANESTHESIA AND ANALGESIA (2020)
Is there benefit o con inue magnesium sulphate postpartum in women receiving magnesium sulphate before delivery? A randomised controlled study
P. Vigil-DeGracia et al.
BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY (2018)
Clinical Experience with the Implementation of Accurate Measurement of Blood Loss during Cesarean Delivery: Influences on Hemorrhage Recognition and Allogeneic Transfusion
Andrew F. Rubenstein et al.
AMERICAN JOURNAL OF PERINATOLOGY (2018)
Clinical pharmacokinetic properties of magnesium sulphate in women with pre-eclampsia and eclampsia
B. O. Okusanya et al.
BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY (2016)
Revisit of risk factors for major obstetric hemorrhage: insights from a large medical center
Sarit Helman et al.
ARCHIVES OF GYNECOLOGY AND OBSTETRICS (2015)
Prediction of postpartum hemorrhage in women with gestational hypertension or mild preeclampsia at term
Corine M. Koopmans et al.
ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA (2014)
Executive Summary of the reVITALize Initiative Standardizing Obstetric Data Definitions
M. Kathryn Menard et al.
OBSTETRICS AND GYNECOLOGY (2014)
Incidence, risk factors, and temporal trends in severe postpartum hemorrhage
Michael S. Kramer et al.
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY (2013)
Clinical Validation of Risk Stratification Criteria for Peripartum Hemorrhage
Andrew J. Dilla et al.
OBSTETRICS AND GYNECOLOGY (2013)
An integrative review of the side effects related to the use of magnesium sulfate for pre-eclampsia and eclampsia management
Jeffrey Michael Smith et al.
BMC PREGNANCY AND CHILDBIRTH (2013)
Effect of a collector bag for measurement of postpartum blood loss after vaginal delivery: cluster randomised trial in 13 European countries
Wei-Hong Zhang et al.
BMJ-BRITISH MEDICAL JOURNAL (2010)
Abnormal bleeding associated with preeclampsia: A population study of 315,085 pregnancies
Anne Eskild et al.
ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA (2009)
Prevalence and risk factors of severe obstetric haemorrhage
I. Al-Zirqi et al.
BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY (2008)
Magnesium ion inhibits spontaneous and induced contractions of isolated uterine muscle
Vlad I. Tica et al.
GYNECOLOGICAL ENDOCRINOLOGY (2007)
Cerebral hemodynamics in preeclampsia: Cerebral perfusion and the rationale for an alternative to magnesium sulfate
Michael A. Belfort et al.
OBSTETRICAL & GYNECOLOGICAL SURVEY (2006)
Obstetric risk factors and outcome of pregnancies complicated with early postpartum hemorrhage: A population-based study
E Sheiner et al.
JOURNAL OF MATERNAL-FETAL & NEONATAL MEDICINE (2005)
The use of standard dose of magnesium sulfate in prophylaxis of eclamptic seizures: Do body mass index alterations have any effect on success?
V Dayicioglu et al.
HYPERTENSION IN PREGNANCY (2003)
Do women with pre-eclampsia, and their babies, benefit from magnesium sulphate? The Magpie Trial: a randomised placebo-controlled trial
L Duley et al.
LANCET (2002)
Pharmacokinetics of ionized versus total magnesium in subjects with preterm labor and preeclampsia
EB Taber et al.
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY (2002)
Magnesium sulfate in eclampsia and pre-eclampsia pharmacokinetic principles
JF Lu et al.
CLINICAL PHARMACOKINETICS (2000)
Share Paper
